SEREVENT DISKUS (50MCG/DOSE) DIN 02231129
Status: Marketed
Holder: GLAXOSMITHKLINE INC
Molecule: SALMETEROL (SALMETEROL XINAFOATE)
Available to quote
Health Canada record
| Active ingredient(s) | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG |
|---|---|
| Dosage form | Powder |
| Route | Inhalation |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | R03AC12 SALMETEROL |
| Original market date | 01-Apr-1998 |
| Current status date | 16-Jan-2003 |
| Source | Health Canada DPD |
Establishment licence of the holder
GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SALMETEROL (SALMETEROL XINAFOATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02245126 | ADVAIR | GLAXOSMITHKLINE INC | Aerosol (Metered-Dose) | SALMETEROL (SALMETEROL XINAFOATE) 25 MCG; FLUTICASONE PROPIONATE 125 MCG | Marketed |
| 02245127 | ADVAIR | GLAXOSMITHKLINE INC | Aerosol (Metered-Dose) | SALMETEROL (SALMETEROL XINAFOATE) 25 MCG; FLUTICASONE PROPIONATE 250 MCG | Marketed |
| 02240835 | ADVAIR 100 DISKUS | GLAXOSMITHKLINE INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG; FLUTICASONE PROPIONATE 100 MCG | Marketed |
| 02240836 | ADVAIR 250 DISKUS | GLAXOSMITHKLINE INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG; FLUTICASONE PROPIONATE 250 MCG | Marketed |
| 02240837 | ADVAIR 500 DISKUS | GLAXOSMITHKLINE INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG; FLUTICASONE PROPIONATE 500 MCG | Marketed |
| 02211742 | SEREVENT (25MCG/ACTUATION) | GLAXOSMITHKLINE INC | Metered-Dose Aerosol | SALMETEROL (SALMETEROL XINAFOATE) 25 MCG | Cancelled Post Market |
| 02214261 | SEREVENT DISKHALER DISK (50MCG/DOSE) | GLAXOSMITHKLINE INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG | Cancelled Post Market |
| 02136139 | SEREVENT- AEM 25MCG/AEM | GLAXO CANADA INC | Metered-Dose Aerosol | SALMETEROL (SALMETEROL XINAFOATE) 25 MCG | Cancelled Post Market |
| 02136147 | SEREVENT-PWR 50MCG/BLISTER PACK | GLAXO CANADA INC | Powder | SALMETEROL (SALMETEROL XINAFOATE) 50 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 2571 | 2001-08-27 | New Drug Submission (NDS) | CHANGE IN MANUFACTURER NAME |
| 2047 | 1999-06-29 | Supplement to a New Drug Submission (SNDS) | NEW DOSAGE FORM |
| 2050 | 1999-05-05 | New Drug Submission (NDS) | |
| 4079 | 1997-04-22 | Supplement to a New Drug Submission (SNDS) | NEW DELIVERY SYSTEM - MULTI-DOSE POWDER INHALER |